National Institutes of Health: Frontotemporal Dementia trials

The registry lists 10 Frontotemporal Dementia studies with National Institutes of Health as lead sponsor. 1 are open to participants now and 3 have results posted.

Phase 1 4Phase 2 3No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal DementiaRecruitingNCT03225144
• Combined Intrathecal and Intravenous VTS-270 Therapy for Liver and Neurological Disease Associated With Niemann-Pick Disease, Type C1TerminatedNCT03887533Phase 1/2Results posted
• Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1CompletedNCT02124083Phase 1/2Results posted
• Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl CysteineCompletedNCT00975689Phase 1/2Results posted
• Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene MutationCompletedNCT01925196
• Living With Frontotemporal DementiaTerminatedNCT01738386
• P-glycoprotein Function in Brain DiseasesCompletedNCT00677885
• PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal DementiaCompletedNCT00613119
• Treatment Study of Frontotemporal DementiaCompletedNCT00088751
• Direct Current Brain Polarization in Frontotemporal DementiaCompletedNCT00077896Phase 1